SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-298463
Filing Date
2014-08-06
Accepted
2014-08-06 17:11:20
Documents
13
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d756095d10q.htm 10-Q 342239
2 EX-10.15 d756095dex1015.htm EX-10.15 16810
3 EX-31.1 d756095dex311.htm EX-31.1 6829
4 EX-31.2 d756095dex312.htm EX-31.2 6535
5 EX-32.1 d756095dex321.htm EX-32.1 7833
12 GRAPHIC g756095ex10_15pg001a.jpg GRAPHIC 1767
13 GRAPHIC g756095ex10_15pg001b.jpg GRAPHIC 912
  Complete submission text file 0001193125-14-298463.txt   3973093

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT srne-20140630.xml EX-101.INS 443905
7 XBRL TAXONOMY EXTENSION SCHEMA srne-20140630.xsd EX-101.SCH 38940
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20140630_cal.xml EX-101.CAL 46099
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20140630_def.xml EX-101.DEF 153160
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20140630_lab.xml EX-101.LAB 357830
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20140630_pre.xml EX-101.PRE 248808
Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121
Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 141020806
SIC: 8731 Services-Commercial Physical & Biological Research